Table 1.
Baseline Characteristics of Normotensive Control Subjects and Hypertensive Retinopathy Patients
| Parameter | Normotensive Controls (n = 31) | Hypertensive Retinopathy (n = 30) |
|---|---|---|
| Age (years) | 53 ± 14 | 55 ± 12 |
| Male (%) | 59.0 | 61.0 |
| Systolic blood pressure (mm Hg) | 115 ± 30 | 154 ± 14* |
| Diastolic blood pressure (mm Hg) | 78 ± 17 | 95 ± 24* |
| Smoke (%) | 31.6 | 29.3 |
| Alcohol drinking (%) | 16.6 | 21.0 |
| Hypertension history, years | – | 13.7 ± 9.2 |
| Hypertensive nephropathy (%) | – | 11.3 |
| Examination | ||
| Cholesterol (mmol/L) | 5.1 ± 1.2 | 5.1 ± 0.9 |
| Triglycerides (mmol/L) | 1.4 ± 0.4 | 1.6 ± 0.8 |
| HDL (mmol/L) | 1.4 ± 0.3 | 1.1 ± 0.6** |
| LDL (mmol/L) | 2.9 ± 0.5 | 2.9 ± 0.7 |
| Creatinemia (μmol/L) | 63.1 ± 23.9 | 77.1 ± 29.9*** |
| Fasting blood glucose (mmol/L) | 5.2 ± 2.3 | 5.2 ± 0.7 |
| White blood cell count (109/L) | 6.1 ± 1.7 | 6.3 ± 2.20 |
| Medications | ||
| ACEI/ARB (%) | – | 21.3 |
| Beta-blocker (%) | – | 50.0 |
| Calcium channel blockers (%) | – | 42.0 |
| Statin (%) | 35.5 | 31.3 |
The parameters are the mean ± SEM or n (%). ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; HDL, high-density lipoprotein; LDL, low-density lipoprotein. *p < 0.001, **p < 0.01, ***p < 0.05 versus control.